Aridis Pharmaceuticals In...
(ARDS)
undefined
undefined%
At close: undefined
0.00
-99.00%
Pre-market Oct 07, 2024, 09:30 AM EDT
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| PE Ratio | -0.72 | -0.68 | -2.54 | -1.3 | -1.58 | -4.16 | -12.18 |
| PS Ratio | n/a | n/a | 55.65 | 36.83 | 12.66 | 119.27 | 45.21 |
| PB Ratio | -0.91 | -2.03 | -6.41 | 10.35 | 1.33 | 8.97 | 7.45 |
| P/FCF Ratio | -0.76 | -1.22 | -2.67 | -4.52 | -1.4 | -5.62 | -16.8 |
| P/OCF Ratio | -0.76 | -1.25 | -2.72 | -4.61 | -1.44 | -5.84 | -16.84 |
| OCF/S Ratio | n/a | n/a | -20.48 | -7.98 | -8.8 | -20.42 | -2.68 |
| Debt / Equity Ratio | -0.18 | -0.42 | -0.08 | n/a | n/a | n/a | n/a |
| Quick Ratio | 0.32 | 0.81 | 0.69 | 1.47 | 5.35 | 7.98 | 9.35 |
| Current Ratio | 0.32 | 0.80 | 0.67 | 1.45 | 4.58 | 7.98 | 9.35 |
| Asset Turnover | n/a | n/a | 0.07 | 0.04 | 0.09 | 0.03 | 0.10 |
| Interest Coverage | -79.35 | 178.41 | n/a | n/a | -57.42 | n/a | -21.54 |
| Return on Equity (ROE) | 1.27 | 3.00 | 2.52 | -7.97 | -0.84 | -2.16 | -0.61 |
| Return on Assets (ROA) | -2.09 | -1.58 | -1.45 | -1.04 | -0.7 | -0.93 | -0.37 |
| Return on Capital (ROIC) | 1.35 | 6.67 | 3.06 | -3.37 | -0.92 | -0.85 | -0.39 |
| Dividend Yield | n/a | 0.14 | n/a | n/a | 0.04 | n/a | n/a |
| Payout Ratio | n/a | -0.1 | n/a | n/a | -0.06 | n/a | n/a |
| Gross Profit Margin | n/a | n/a | 100.00% | 100.00% | 100.00% | 100.00% | 15.07% |
| Net Profit Margin | n/a | n/a | -2.19K% | -2.84K% | -801.78% | -2.87K% | -371.18% |
| Pretax Profit Margin | n/a | n/a | -2.23K% | -2.90K% | -801.78% | -2.87K% | -371.18% |
| Operating Profit Margin | n/a | n/a | -2.24K% | -2.85K% | -874.76% | -2.30K% | -347.47% |
| FCF Margin | n/a | n/a | -2.08K% | -815.36% | -904.9% | -2.12K% | -269.11% |
| EBITDA Margin | n/a | n/a | -2.21K% | -2.81K% | -864.49% | -2.29K% | -346.45% |